Aire Advisors, LLC Merck & Co., Inc. Transaction History

Aire Advisors, LLC

$443 Million
Q3 2024

A detailed history of Aire Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Aire Advisors, LLC holds 4,222 shares of MRK stock, worth $415,191. This represents 0.11% of its overall portfolio holdings.

Number of Shares

4,222

Previous 4,243 0.49%

Holding current value

$415,191

Previous $525,000 8.76%

% of portfolio

0.11%

Previous 0.12%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $2,334 - $2,708	-21 Reduced 0.49%	4,222 $479,000
Q2 2024 Aug 01, 2024	BUY	$123.8 - $132.96 $2,476 - $2,659	20 Added 0.47%	4,243 $525,000
Q1 2024 May 13, 2024	BUY	$113.24 - $131.95 $16,646 - $19,396	147 Added 3.61%	4,223 $557,000
Q4 2023 Jan 29, 2024	SELL	$100.18 - $109.02 $3,706 - $4,033	-37 Reduced 0.9%	4,076 $444,000
Q3 2023 Oct 30, 2023	BUY	$102.95 - $114.33 $2,059 - $2,286	20 Added 0.49%	4,113 $423,000
Q2 2023 Aug 02, 2023	BUY	$108.61 - $118.38 $2,389 - $2,604	22 Added 0.54%	4,093 $472,000
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $58,675 - $65,470	-570 Reduced 12.28%	4,071 $433,000
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $31,653 - $40,583	-362 Reduced 7.24%	4,641 $514,000
Q3 2022 Oct 28, 2022	SELL	$84.53 - $94.96 $24,598 - $27,633	-291 Reduced 5.5%	5,003 $431,000
Q2 2022 Aug 08, 2022	BUY	$83.49 - $94.64 $27,969 - $31,704	335 Added 6.76%	5,294 $478,000
Q1 2022 May 06, 2022	SELL	$73.51 - $82.4 $53,221 - $59,657	-724 Reduced 12.74%	4,959 $407,000
Q4 2021 Feb 09, 2022	BUY	$72.28 - $90.54 $410,767 - $514,538	5,683 New	5,683 $435,000

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aire Advisors, LLC with notifications on news.

Account

Aire Advisors, LLC Merck & Co., Inc. Transaction History